In a high proportion of NMOsd patients, brain lesions are also present [4], [5], thus complicating diagnosis, and the detection of anti-AQP4 antibodies is therefore vital for the early differentiation of NMO from MS [6] and for appropriate treatment [7]. Here, AQP4 is linked to myeloid sarcoma.